Publication: Therapeutic miR-21 Silencing Ameliorates Diabetic Kidney Disease in Mice
Therapeutic miR-21 Silencing Ameliorates Diabetic Kidney Disease in Mice
Date
Date
Date
Citations
Kölling, M., Kaucsar, T., Schauerte, C., Hübner, A., Dettling, A., Park, J.-K., Busch, M., Wulff, X., Meier, M., Scherf, K., Bukosza, N., Szénási, G., Godó, M., Sharma, A., Heuser, M., Hamar, P., Bang, C., Haller, H., Thum, T., & Lorenzen, J. M. (2017). Therapeutic miR-21 Silencing Ameliorates Diabetic Kidney Disease in Mice. Molecular Therapy, 25, 165–180. https://doi.org/10.1016/j.ymthe.2016.08.001
Abstract
Abstract
Abstract
Diabetic nephropathy is the main cause of end-stage renal disease. MicroRNAs are powerful regulators of the genome, and global expression profiling revealed miR-21 to be among the most highly regulated microRNAs in kidneys of mice with diabetic nephropathy. In kidney biopsies of diabetic patients, miR-21 correlated with tubulointerstitial injury. In situ PCR analysis showed a specific enrichment of miR-21 in glomerular cells. We identified cell division cycle 25a (Cdc25a) and cyclin-dependent kinase 6 (Cdk6) as novel miR-21 targets in
Metrics
Downloads
Views
Additional indexing
Creators (Authors)
Volume
Volume
Volume
Number
Number
Number
Page range/Item number
Page range/Item number
Page range/Item number
Page end
Page end
Page end
Item Type
Item Type
Item Type
In collections
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
OA Status
OA Status
OA Status
Free Access at
Free Access at
Free Access at
Publisher DOI
Metrics
Downloads
Views
Citations
Kölling, M., Kaucsar, T., Schauerte, C., Hübner, A., Dettling, A., Park, J.-K., Busch, M., Wulff, X., Meier, M., Scherf, K., Bukosza, N., Szénási, G., Godó, M., Sharma, A., Heuser, M., Hamar, P., Bang, C., Haller, H., Thum, T., & Lorenzen, J. M. (2017). Therapeutic miR-21 Silencing Ameliorates Diabetic Kidney Disease in Mice. Molecular Therapy, 25, 165–180. https://doi.org/10.1016/j.ymthe.2016.08.001